Industry: Chemical & Material
Published Date: 2024-01-16
Pages: 126 Pages
Report ld: 2223742
Request Sample
Customized Report
The global market for Neohesperidoside was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Neohesperidoside was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Neohesperidoside was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Neohesperidoside was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Neohesperidoside include Biospringer, BASF SE, Cargill, Chr.Hansen Holding A/S, Corbion NV, CP Kelco, DowDuPont, Edlong Dairy Technologies and Firmenich SA, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Neohesperidoside, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Neohesperidoside by region & country, by Type, and by Application.
The Neohesperidoside market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neohesperidoside.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Neohesperidoside manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Neohesperidoside in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Neohesperidoside in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Neohesperidoside Product Introduction
1.2 Global Neohesperidoside Market Size Forecast
1.2.1 Global Neohesperidoside Sales Value (2019-2030)
1.2.2 Global Neohesperidoside Sales Volume (2019-2030)
1.2.3 Global Neohesperidoside Sales Price (2019-2030)
1.3 Neohesperidoside Market Trends & Drivers
1.3.1 Neohesperidoside Industry Trends
1.3.2 Neohesperidoside Market Drivers & Opportunity
1.3.3 Neohesperidoside Market Challenges
1.3.4 Neohesperidoside Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Neohesperidoside Players Revenue Ranking (2023)
2.2 Global Neohesperidoside Revenue by Company (2019-2024)
2.3 Global Neohesperidoside Players Sales Volume Ranking (2023)
2.4 Global Neohesperidoside Sales Volume by Company Players (2019-2024)
2.5 Global Neohesperidoside Average Price by Company (2019-2024)
2.6 Key Manufacturers Neohesperidoside Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Neohesperidoside Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Neohesperidoside
2.9 Neohesperidoside Market Competitive Analysis
2.9.1 Neohesperidoside Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Neohesperidoside Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neohesperidoside as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Food Grade
3.1.2 Industrial Grade
3.1.3 Pharmacy Grade
3.2 Global Neohesperidoside Sales Value by Type
3.2.1 Global Neohesperidoside Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Neohesperidoside Sales Value, by Type (2019-2030)
3.2.3 Global Neohesperidoside Sales Value, by Type (%) (2019-2030)
3.3 Global Neohesperidoside Sales Volume by Type
3.3.1 Global Neohesperidoside Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Neohesperidoside Sales Volume, by Type (2019-2030)
3.3.3 Global Neohesperidoside Sales Volume, by Type (%) (2019-2030)
3.4 Global Neohesperidoside Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food
4.1.2 Cosmetics
4.1.3 Medicine
4.2 Global Neohesperidoside Sales Value by Application
4.2.1 Global Neohesperidoside Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Neohesperidoside Sales Value, by Application (2019-2030)
4.2.3 Global Neohesperidoside Sales Value, by Application (%) (2019-2030)
4.3 Global Neohesperidoside Sales Volume by Application
4.3.1 Global Neohesperidoside Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Neohesperidoside Sales Volume, by Application (2019-2030)
4.3.3 Global Neohesperidoside Sales Volume, by Application (%) (2019-2030)
4.4 Global Neohesperidoside Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Neohesperidoside Sales Value by Region
5.1.1 Global Neohesperidoside Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Neohesperidoside Sales Value by Region (2019-2024)
5.1.3 Global Neohesperidoside Sales Value by Region (2025-2030)
5.1.4 Global Neohesperidoside Sales Value by Region (%), (2019-2030)
5.2 Global Neohesperidoside Sales Volume by Region
5.2.1 Global Neohesperidoside Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Neohesperidoside Sales Volume by Region (2019-2024)
5.2.3 Global Neohesperidoside Sales Volume by Region (2025-2030)
5.2.4 Global Neohesperidoside Sales Volume by Region (%), (2019-2030)
5.3 Global Neohesperidoside Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Neohesperidoside Sales Value, 2019-2030
5.4.2 North America Neohesperidoside Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Neohesperidoside Sales Value, 2019-2030
5.5.2 Europe Neohesperidoside Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Neohesperidoside Sales Value, 2019-2030
5.6.2 Asia Pacific Neohesperidoside Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Neohesperidoside Sales Value, 2019-2030
5.7.2 South America Neohesperidoside Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Neohesperidoside Sales Value, 2019-2030
5.8.2 Middle East & Africa Neohesperidoside Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Neohesperidoside Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Neohesperidoside Sales Value
6.2.1 Key Countries/Regions Neohesperidoside Sales Value, 2019-2030
6.2.2 Key Countries/Regions Neohesperidoside Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Neohesperidoside Sales Value, 2019-2030
6.3.2 United States Neohesperidoside Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Neohesperidoside Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Neohesperidoside Sales Value, 2019-2030
6.4.2 Europe Neohesperidoside Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Neohesperidoside Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Neohesperidoside Sales Value, 2019-2030
6.5.2 China Neohesperidoside Sales Value by Type (%), 2023 VS 2030
6.5.3 China Neohesperidoside Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Neohesperidoside Sales Value, 2019-2030
6.6.2 Japan Neohesperidoside Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Neohesperidoside Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Neohesperidoside Sales Value, 2019-2030
6.7.2 South Korea Neohesperidoside Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Neohesperidoside Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Neohesperidoside Sales Value, 2019-2030
6.8.2 Southeast Asia Neohesperidoside Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Neohesperidoside Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Neohesperidoside Sales Value, 2019-2030
6.9.2 India Neohesperidoside Sales Value by Type (%), 2023 VS 2030
6.9.3 India Neohesperidoside Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Biospringer
7.1.1 Biospringer Company Information
7.1.2 Biospringer Introduction and Business Overview
7.1.3 Biospringer Neohesperidoside Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Biospringer Neohesperidoside Product Offerings
7.1.5 Biospringer Recent Development
7.2 BASF SE
7.2.1 BASF SE Company Information
7.2.2 BASF SE Introduction and Business Overview
7.2.3 BASF SE Neohesperidoside Sales, Revenue and Gross Margin (2019-2024)
7.2.4 BASF SE Neohesperidoside Product Offerings
7.2.5 BASF SE Recent Development
7.3 Cargill
7.3.1 Cargill Company Information
7.3.2 Cargill Introduction and Business Overview
7.3.3 Cargill Neohesperidoside Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Cargill Neohesperidoside Product Offerings
7.3.5 Cargill Recent Development
7.4 Chr.Hansen Holding A/S
7.4.1 Chr.Hansen Holding A/S Company Information
7.4.2 Chr.Hansen Holding A/S Introduction and Business Overview
7.4.3 Chr.Hansen Holding A/S Neohesperidoside Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Chr.Hansen Holding A/S Neohesperidoside Product Offerings
7.4.5 Chr.Hansen Holding A/S Recent Development
7.5 Corbion NV
7.5.1 Corbion NV Company Information
7.5.2 Corbion NV Introduction and Business Overview
7.5.3 Corbion NV Neohesperidoside Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Corbion NV Neohesperidoside Product Offerings
7.5.5 Corbion NV Recent Development
7.6 CP Kelco
7.6.1 CP Kelco Company Information
7.6.2 CP Kelco Introduction and Business Overview
7.6.3 CP Kelco Neohesperidoside Sales, Revenue and Gross Margin (2019-2024)
7.6.4 CP Kelco Neohesperidoside Product Offerings
7.6.5 CP Kelco Recent Development
7.7 DowDuPont
7.7.1 DowDuPont Company Information
7.7.2 DowDuPont Introduction and Business Overview
7.7.3 DowDuPont Neohesperidoside Sales, Revenue and Gross Margin (2019-2024)
7.7.4 DowDuPont Neohesperidoside Product Offerings
7.7.5 DowDuPont Recent Development
7.8 Edlong Dairy Technologies
7.8.1 Edlong Dairy Technologies Company Information
7.8.2 Edlong Dairy Technologies Introduction and Business Overview
7.8.3 Edlong Dairy Technologies Neohesperidoside Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Edlong Dairy Technologies Neohesperidoside Product Offerings
7.8.5 Edlong Dairy Technologies Recent Development
7.9 Firmenich SA
7.9.1 Firmenich SA Company Information
7.9.2 Firmenich SA Introduction and Business Overview
7.9.3 Firmenich SA Neohesperidoside Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Firmenich SA Neohesperidoside Product Offerings
7.9.5 Firmenich SA Recent Development
7.10 FMC Health and Nutrition
7.10.1 FMC Health and Nutrition Company Information
7.10.2 FMC Health and Nutrition Introduction and Business Overview
7.10.3 FMC Health and Nutrition Neohesperidoside Sales, Revenue and Gross Margin (2019-2024)
7.10.4 FMC Health and Nutrition Neohesperidoside Product Offerings
7.10.5 FMC Health and Nutrition Recent Development
8 Industry Chain Analysis
8.1 Neohesperidoside Industrial Chain
8.2 Neohesperidoside Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Neohesperidoside Sales Model
8.5.2 Sales Channel
8.5.3 Neohesperidoside Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Neohesperidoside market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 78
USD 4250.00
(Single User License)
The global Neohesperidoside market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 133
USD 4900.00
(Single User License)
The global market for Neohesperidoside was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 108
USD 3950.00
(Single User License)
The global Neohesperidoside market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 129
USD 2900.00
(Single User License)
The global Neohesperidoside market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 145
USD 4900.00
(Single User License)
The global market for Neohesperidoside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-14
Pages: 102
USD 3950.00
(Single User License)
The global Neohesperidoside market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-14
Pages: 80
USD 4250.00
(Single User License)
The global market for Neohesperidoside was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-08-14
Pages: 92
USD 2900.00
(Single User License)
The global market for Neohesperidoside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 97
USD 3950.00
(Single User License)
The global Neohesperidoside market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 95
USD 2900.00
(Single User License)
The global Neohesperidoside market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 78
The global Neohesperidoside market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 133
The global market for Neohesperidoside was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 108
The global Neohesperidoside market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 129
The global Neohesperidoside market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 145
The global market for Neohesperidoside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-14
Pages: 102
The global Neohesperidoside market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-14
Pages: 80
The global market for Neohesperidoside was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-08-14
Pages: 92
The global market for Neohesperidoside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 97
The global Neohesperidoside market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 95
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now